1367905-79-0

Basic information

• Product Name: 5-broMo-2-Methylisoquinolin-1(2H)-one
• Synonyms: 5-broMo-2-Methylisoquinolin-1(2H)-one;5-bromo-2-methyl-1,2-dihydroisoquinolin-1-one
• CAS NO: 1367905-79-0
• Molecular Formula: C10H8BrNO
• Molecular Weight: 238.08062
• Mol File: 1367905-79-0.mol

Chemical Properties

• Boiling Point: 373.4±42.0 °C(Predicted)
• Appearance: /
• Density: 1.553±0.06 g/cm3(Predicted)
• PKA: -2.67±0.70(Predicted)
• CAS DataBase Reference: 5-broMo-2-Methylisoquinolin-1(2H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-broMo-2-Methylisoquinolin-1(2H)-one(1367905-79-0)
• EPA Substance Registry System: 5-broMo-2-Methylisoquinolin-1(2H)-one(1367905-79-0)

Safety Data

• Hazardous Substances Data: 1367905-79-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Chemistry:
5-Bromo-2-methylisoquinolin-1(2H)-one is used as a reagent in organic chemistry for its versatile reactions in various synthesis processes.
Used in Pharmaceutical Applications:
5-Bromo-2-methylisoquinolin-1(2H)-one is used as a building block in the development of new drugs and medicinal compounds due to its potential in pharmaceutical applications.

Upstream product

• 34784-04-8 5-bromoisoquinoline 
• 74-88-4 methyl iodide 
• 15115-60-3 4-bromo-2,3-dihydroinden-1-one 
• 1109230-25-2 5-bromo-1,2,3,4-tetrahydroisoquinolin-1-one 
• 190777-77-6 5-bromo-1,2-dihydroisoquinolin-1-one 

Relevant articles and documents

Visible-Light-Mediated Aerobic Oxidation of N-Alkylpyridinium Salts under Organic Photocatalysis

Quinolones and isoquinolones exhibit diverse biological and pharmaceutical activities, and their synthesis is highly desirable under mild conditions. Here, a highly efficient and environmentally friendly visible light-mediated aerobic oxidation of readily available N-alkylpyridinium salts has been developed with Eosin Y as the organic photocatalyst and air as the terminal oxidant, and the reaction provided quinolones and isoquinolones in good yields. The method shows numerous advantages including mild and environmentally friendly conditions, high efficiency, tolerance of wide functional groups and low cost. Furthermore, 4-desoxylonimide with important pharmaceutical activities was effectively prepared by using our method. Therefore, the present method should provide a novel and useful strategy for synthesis and modification of N-heterocycles.

Covalent Organic Frameworks toward Diverse Photocatalytic Aerobic Oxidations

Photoactive two-dimensional covalent organic frameworks (2D-COFs) have become promising heterogenous photocatalysts in visible-light-driven organic transformations. Herein, a visible-light-driven selective aerobic oxidation of various small organic molecules by using 2D-COFs as the photocatalyst was developed. In this protocol, due to the remarkable photocatalytic capability of hydrazone-based 2D-COF-1 on molecular oxygen activation, a wide range of amides, quinolones, heterocyclic compounds, and sulfoxides were obtained with high efficiency and excellent functional group tolerance under very mild reaction conditions. Furthermore, benefiting from the inherent advantage of heterogenous photocatalysis, prominent sustainability and easy photocatalyst recyclability, a drug molecule (modafinil) and an oxidized mustard gas simulant (2-chloroethyl ethyl sulfoxide) were selectively and easily obtained in scale-up reactions. Mechanistic investigations were conducted using radical quenching experiments and in situ ESR spectroscopy, all corroborating the proposed role of 2D-COF-1 in photocatalytic cycle.

PROCESS FOR PREPARING A COT INHIBITOR COMPOUND

Disclosed are syntheses of a Cot (cancer Osaka thyroid) inhibitor, which has the formula (I).

Carbene-catalyzed aerobic oxidation of isoquinolinium salts: Efficient synthesis of isoquinolinones

A mild and environmentally friendly carbene-catalyzed aerobic oxidation of isoquinolinium salts was successfully realized. Accordingly, a diverse set of isoquinolinones and phenanthridinones was efficiently prepared in good to excellent yields. The mechanistic study indicates that the formation of an aza-Breslow intermediate is the crucial step in this transformation. This reaction features ambient air as the sole oxidant and oxygen source, a broad substrate scope, and excellent functional-group tolerance and proceeds under mild reaction conditions. Furthermore, a highly efficient synthesis of bioactive molecules and natural products including N-methylcrinasiadine, N-isopentylcrinasiadine, N-phenethylcrinasiadine, isoindolo[2,1-b]isoquinolin-5(7H)-one, PJ-34, rac-Gusanlung D, rosettacin, 8-oxopseudopalmatine and ilicifoline B was accomplished.

CARBAZOLE COMPOUNDS AND METHODS OF USING SAME

The present invention provides carbazole compounds of the formula (I), which can be used for treating microbial, protozoan, viral infections and cancer. ?

FUSED INDOLE COMPOUNDS AND METHODS OF USING SAME

The invention relates to fused indole compounds of formula (I) that can be used for treating microbial infections, in particular, fungal infections, and selectively kill cancer cells.

CARBAZOLE COMPOUNDS AND METHODS OF USING SAME

The invention relates to carbazole compounds of formula (I) that can be used for treating microbial infections, in particular, fungal infections, and selectively kill cancer cells.

PYRIMIDO-DIAZEPINONE COMPOUND

Provided are a compound represented by general formula (I), or the pharmaceutically acceptable salt thereof, (wherein Ra represents a hydrogen atom or the like, R1 and R2 may be the same or different, and each represents a hydrogen atom, optionally substituted lower alkyl or cycloalkyl, or R1 and R2 are combined together with the adjacent nitrogen atom thereto to form nitrogen-containing heterocyclic group, and Z represents a bicyclic heterocyclic group in which optionally substituted two six-membered rings are fused to each other, or the like) and the like.